发明名称 |
Antibodies to ox-2/cd200 and uses thereof |
摘要 |
<p>Patent No. 599035 Disclosed is an isolated anti-CD200 antibody that: (i) inhibits the interaction between CD200 and CD200R; and (ii) comprises a variant Fc constant region that has ADCC activity or CDC activity equal to or less than the ADCC activity or CDC activity of a G2/G4 Fc constant region consisting of amino acid residues 137-462 of MGWSRIFLFLLSIIAGVHCQVQLQQSGSELKKPGASVKISCKASGYSFTDYTILWVRQNPGKGLEWIGHIDPYYGSSNYNLKPKGRVTITADQSTTTAYMELSSLRSEDTAVYYCGRSKRDYFDYWGQGTTLTVSSASTKGPSVFPLAPCSRSTSESTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSNFGTQTYTCNVDHKPSNTKVDKTVERKCCVECPPCPAPPVAGPSVFLFPPKPKDTLNUSRTPEVTCVVVDVSQEDPEVQFNVVYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRL TVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK.</p> |
申请公布号 |
NZ599035(A) |
申请公布日期 |
2013.12.20 |
申请号 |
NZ20070599035 |
申请日期 |
2007.01.11 |
申请人 |
ALEXION PHARMACEUTICALS INC. |
发明人 |
BOWDISH KATHERINE S.;KRETZ-ROMMEL ANKE;FAAS SUSAN MCKNIGHT;SPRINGHORN JEREMY P;WU DAYANG |
分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|